Skip to Content

MYLAN 6089 MYLAN 6089 (Fenofibrate (micronized) 130 mg)

Pill imprint MYLAN 6089 MYLAN 6089 has been identified as Fenofibrate (micronized) 130 mg.

Fenofibrate is used in the treatment of hypertriglyceridemia; hyperlipoproteinemia; hyperlipoproteinemia type iia, elevated ldl; hyperlipoproteinemia type iib, elevated ldl vldl; hyperlipoproteinemia type iv, elevated vldl (and more), and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibrate 130 mg is not a controlled substance under the Controlled Substance Act (CSA).

Fenofibrate (micronized) 130 mg MYLAN 6089 MYLAN 6089
Fenofibrate (micronized) 130 mg MYLAN 6089 MYLAN 6089
Discount Card Promo
Fenofibrate (micronized)
MYLAN 6089 MYLAN 6089
130 mg
Prescription only
Drug Class:
Fibric acid derivatives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Mylan Pharmaceuticals Inc.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.